Arm Holdings reported fiscal third-quarter results that topped Wall Street estimates and raised the midpoint of its narrowed sales outlook. ...
Tariffs proposed by President Donald Trump could disrupt supply chains and stoke inflation, much like the cascade of price increases that ripped through the economy during the pandemic, one official ...
Cutting out alcohol can save you more than just a few headaches. It can also boost your budget. Here's how much you could save by skipping booze.
Alphabet shares fell sharply Wednesday as investors responded to the Google parent's weaker-than-expected revenue numbers and big AI spending plans. Monitor these important chart levels.
Chipotle sources half its avocados from countries other than Mexico, said CEO Scott Boatwright on the company's earnings call Tuesday. That could help shield it from the 25% tariff President Trump has ...
Shares of FMC Corp. lost roughly a third of their value Wednesday, making the stock by far the biggest decliner in the S&P 500 after it reported a surprise net loss for the fourth quarter.
Shares of several tech companies specializing in artificial intelligence products soared Wednesday after Google parent Alphabet said it plans to ramp up spending on AI.
With a little patience and a big helping hand from compound interest, it's not that difficult to turn $5,000 into $1 million.
Shares of Google parent Alphabet tumbled Wednesday as several analysts lowered their price targets for the stock, citing concerns about the tech giant's weaker-than-expected cloud growth and plans to ...
First-time buyers “are proving to be more resilient" than previously thought, even as home prices and mortgage rates remain elevated, economists at the New York Fed said.
Workday announced in a regulatory filing Wednesday that it plans to lay off approximately 1,750 employees, or 8.5% of its workforce, as part of a restructuring plan.
GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of optimism about sales of its new drugs ...